Article thumbnail

Protein C Activity in Dogs: Adaptation of a Commercial Human Colorimetric Assay and Evaluation of Effects of Storage Time and Temperature

By Michael M. Fry, Karl R. Snyder, Karen M. Tobias, Baye G. Williamson and G. Ann Reed

Abstract

Objectives of this study were to adapt a commercial human protein C (PC) colorimetric assay for use in dogs and to investigate effects of various storage conditions. The human assay was modified by using pooled canine plasma for calibration and by increasing the activation time. PC activity was measured in fresh canine plasma and in plasma stored under various conditions. PC activity of some stored samples was significantly different from that of fresh plasma; however, differences were small. No difference was detected in samples stored under similar conditions but analyzed in different laboratories using similar methodology. Results of this study indicate that the human colorimetric assay is suitable for canine samples if pooled canine plasma is used for calibration, that Clinical and Laboratory Standards Institute sample storage guidelines developed for testing in humans are appropriate for dogs, and that comparisons of results from laboratories using similar methodology are legitimate

Topics: Research Article
Publisher: SAGE-Hindawi Access to Research
OAI identifier: oai:pubmedcentral.nih.gov:3139207
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). A .d eL a f o r c a d e ,E .A .R o z a n s k i ,L .M .F r e e m a n ,a n dW .L i , “Serial evaluation of protein C and antithrombin in dogs with sepsis,”
  2. (2003). A .M .d eL a f o r c a d e ,L .M .F r e e m a n
  3. (2002). A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity,” Blood,v o l .9 9 ,n o .7 ,p p .
  4. (2001). a z b i k ,C .G .C o u t o ,T .L .G r a y ,a n dG .K o c i b a ,“ E ffect of storageconditionsonhemostaticparameters ofcanineplasma obtained for transfusion,”
  5. (2010). Castellino,“TheproteinCpathwayintissueinflammationand injury: pathogenic role and therapeutic implications,”
  6. (2008). Clinical and clinicopathologic features of dogs that consumed foodborne hepatotoxic aflatoxins:72cases (2005-2006),”Journal of the
  7. (2010). Coagulation disorders in dogs with hepatic disease,”
  8. (2000). Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog,”
  9. (2010). Comparative stability of canine and feline hemostatic proteins in freezethaw-cycled fresh frozen plasma,”
  10. d c o c k ,D .H o e f n e r ,K .K o t t k e - M a r c h a n t ,R .M a r l a r
  11. (1998). i s c h k e ,D .P ¨ o h l e ,H .A .S c h o o n ,M .F e h r ,a n dI .N o l t e , “Alterations of hemostasis in liver cirrhosis of the dog,”
  12. (1998). Influence of time and temperature on coagulation analytes in stored plasma,”
  13. (2002). Laboratory issues in diagnosingabnormalities of protein C, thrombomodulin,and endothelial cell protein
  14. (1999). N e i l l ,J .R o w l e y ,M .H a n s s o n - W i c h e r ,S .M c C a r t e r
  15. (2004). Natural anticoagulant inhibitors: activated Protein C,” Best Practice and Research—Clinical Haematology,
  16. (2006). o u l z a ,S .A .C e n t e r ,M .B .B r o o k s
  17. (2006). Performance goals for the laboratory testing of antithrombin protein
  18. (2009). Reference intervals and method optimizationfor variables reflecting hypocoagulatory and hypercoagulatory states in dogs using the STA Compact automated analyzer,”
  19. (2001). Stability of coagulation proteins
  20. Tidholm et al., “Hemostatic biomarkers in dogs with chronic congestive heart failure,”